致密乳腺的筛查策略:AJR 专家小组叙述性综述
该综述指出,数字乳腺断层合成(DBT)是减少召回的首选乳腺摄影技术,超声、分子乳腺成像(MBI)、MRI 和对比增强乳腺摄影(CEM)在致密乳腺中均较二维数字乳腺摄影(DM)提高癌症检出。DBT 与超声可减少间隔癌但增加假阳性,MRI 检出增益最大,CEM 表现似 MRI 但需进一步验证。
要点
- DBT 是致密乳腺首选的乳腺摄影技术,可同时减少召回(即额外影像检查)。
- 超声在 DM 或 DBT 后进一步提高癌症检出并减少间隔癌,但产生大量额外假阳性。
- MRI 的癌症检出增益最大,并减少间隔癌和晚期病变;CEM 表现似 MRI 但需进一步验证。
诊断标准与关键数值
- 与二维数字乳腺摄影(DM)相比,DBT、超声、MBI、MRI 和 CEM 在致密乳腺中均显示提高癌症检出。
- MBI 的有效辐射剂量约为 DM 或 DBT 的四倍,但仍在可接受范围内。
临床应用与阅片要点
- DBT 是致密乳腺首选的乳腺摄影技术,可在减少召回的同时提高癌症检出。
- 超声可在 DM 或 DBT 后追加使用以提高癌症检出并减少间隔癌,但会产生大量额外假阳性。
- MRI 提供最大的癌症检出增益并减少间隔癌和晚期病变;缩短方案可降低成本并改善可及性。
- CEM 表现似乎与 MRI 相似,但尚需进一步验证。
- 致密乳腺通知即将成为国家标准化要求,理解乳腺摄影和补充模态的性能对优化致密乳腺筛查是必要的。
局限性
- CEM 表现似 MRI 但尚需进一步验证。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Screening mammography reduces breast cancer mortality; however, when used to examine women with dense breasts, its performance and resulting benefits are reduced. Increased breast density is an independent risk factor for breast cancer. Digital breast tomosynthesis (DBT), ultrasound (US), molecular breast imaging (MBI), MRI, and contrast-enhanced mammography (CEM) each have shown improved cancer detection in dense breasts when compared with 2D digital mammography (DM). DBT is the preferred mammographic technique for producing a simultaneous reduction in recalls (i.e., additional imaging). US further increases cancer detection after DM or DBT and reduces interval cancers (cancers detected in the interval between recommended screening examinations), but it also produces substantial additional false-positive findings. MBI improves cancer detection with an effective radiation dose that is approximately fourfold that of DM or DBT but is still within accepted limits. MRI provides the greatest increase in cancer detection and reduces interval cancers and late-stage disease; abbreviated techniques will reduce cost and improve availability. CEM appears to offer performance similar to that of MRI, but further validation is needed. Dense breast notification will soon be a national standard; therefore, understanding the performance of mammography and supplemental modalities is necessary to optimize screening for women with dense breasts.
引用
- Berg WA, Rafferty EA, Friedewald SM, et al. Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review. AJR Am J Roentgenol. 2020. PMID: 32903054. doi:10.2214/AJR.20.24436
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。